← Back to all trials
Not Yet Recruiting
NCT07868393
Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition From the Emergency Department
Conditions: Opioid Overdose Prevention, HIV Prevention and Care, Harm Reduction
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 120
Sponsor: Johns Hopkins University
Location: The Johns Hopkins Hospital Emergency Department Baltimore Maryland
Summary
The Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition from the Emergency Department (PROTECT-ED) study evaluates an emergency department-based implementation strategy designed to improve delivery of evidence-based overdose and HIV prevention services during community re-entry.
Eligibility Criteria
Inclusion Criteria:
* Are 18 years of age or older.
* Present to the Johns Hopkins Hospital Emergency Department.
* Have been released within the previous 180 days from a prison, jail, juvenile detention facility, immigration detention facility, halfway house, residential reentry center, or other correctional setting. Recent incarceration may be confirmed through participant self-report, electronic medical record documentation, the Victim Information and Notification Everyday (VINE) system, or other available documentation. Participant self-report alone is sufficient to establish eligibility.
* Meet criteria for opioid use disorder or hazardous opioid use and are considered appropriate for evaluation for medications for opioid use disorder (MOUD) or are at risk for HIV acquisition.
* Able to speak and understand communicate in English sufficiently to provide informed consent and complete study assessments.
* Provide informed consent.
* Have a reliable telephone number for study follow-up.
Exclusion Criteria:
* Inability to provide informed consent during the index emergency department encounter.
* Lack of a reliable telephone number for study follow-up.
* Prior enrollment in the PROTECT-ED study.
Source: ClinicalTrials.gov (NCT07868393). StuddyBuddy aggregates publicly available trial information.